Customized natural medicines…homeopathy…health coaches and nutritionists. These are some of the mainstays of natural medicine, yet they are threatened from many sides.
Compounded, customized medicines are facing extinction because of FDA regulations. Bioidentical hormones (like estriol and progesterone) and thyroid medications made for vulnerable populations with special needs (such as breast cancer patients and people with autism) are on the chopping block. So are intravenous nutrients made for patients who often have an adverse reaction to mass-manufactured drugs, and need a more tailored treatment to boost their immune system and digestive function.
These customized medicines cut into the profits of pharmaceutical companies, who don’t want the competition.
There are other problems. Our healthcare choices are being limited in other ways, too. Trade groups are attempting to carve out state-level monopolies, restricting who can offer nutrition advice and narrowing consumer choice.
Meanwhile, the FTC and the FDA are staging a war against homeopathy, chelation, and other natural remedies that don’t fit within a narrow scope of what some officials consider the “standard of practice.”
Join ANH-USA in the fight to preserve freedom of choice in healthcare!
Victories We’ve Brought About To Protect Compounding:
- Retained non-standardized doses, allowing compounders and doctors to continue practicing personalized medicine.
- Removed the RCT provision from a Senate bill that would have banned compounded medications.
- Removed the “Substantiated Need” provision, protecting a doctor’s right to practice personalized medicine.
- Removed the “10% Rule” from the compounding bill that became law, a draconian measure that would have crippled compounding pharmacies.
- Saved progesterone medicine that is vital in preventing preterm birth.
- Nominated two important drugs for inclusion on FDA’s list of bulk drugs that may be compounded.
To Prevent Dietetics Monopolies:
- Replaced a monopolistic Illinois law, allowing nutritionists to be recognized providers.
- Defeated anti-competitive legislation in California that would have monopolized nutrition advice.
- Won battles in Delaware and Michigan for Certified Nutrition Specialists.
- Advanced Older Americans CARE Act to allow good nutrition advice for the elderly.
- Achieved 19 state wins & counting– We are winning the fight against nutrition monopolies around the country.
Feb 20, 2020 82
This search engine monopolist is preventing you from learning about natural health, and instead promoting prescription drugs. Action Alert! Last year, we told you about the aggressive censorship campaign that Google and other Internet gatekeepers have embarked upon. This censorship is preventing ...
Feb 6, 2020 115
California is threatening to ban methylcobalamin shots, which sets a dangerous precedent. We must act now. Action Alerts! The California State Board of Pharmacy has proposed regulatory language that would block patient access to methylcobalamin (B12) injections, IV glutathione, intranasal glutath...
Dec 19, 2019 26
Emerging research underscores the critical need to protect compounded bioidentical hormones. Action Alert! Almost six million Americans suffer from Alzheimer’s disease, and it is projected to afflict many more in coming years. Big Pharma has been unable to produce drugs that treat this debilita...
Nov 21, 2019 212
The agency is doubling down on a bad guidance that endangers access to important medicines. Action Alert! Recently, the FDA announced the withdrawal of Compliance Policy Guide 400.400, a document that had been in place since 1988 and which established the agency’s enforcement policies regarding...
Nov 21, 2019 14
“Approved” “Hormone Therapy” For Women is Mostly Not Bio-Identical, is “One-Size-Fits-All,” and Not Safe for Use
The following article is by Dr. Jonathan V. Wright. The original article appears in the November 2019 issue of the Green Medicine Newsletter. Action Alert! The September 24th issue of the Journal of the American Medical Association (“JAMA”) reprinted an article originally published in The...
Nov 7, 2019 274
An update in the fight to protect estriol and other hormones from an FDA ban. Action Alert! We’ve said before that the FDA is stacking the deck against bioidentical hormones; now it seems incontrovertible. Time is running out for the natural health community to mount an effective defense o...
Oct 22, 2019 17
The FDA is holding a public hearing on the use of fecal microbiota transfer (FMT) to treat a bacterial infection. Are they paving the way to hand FMT to Big Pharma? Action Alert! The FDA announced a public meeting for November 4 of this year. The stated purpose of the meeting is to gather scienti...
Oct 20, 2019 86
Help us defend bioidentical hormone replacement therapy from an FDA ban. Action Alert! We at ANH-USA have been keeping a close watch over the FDA’s ongoing process to regulate customized, natural medicines made at compounding pharmacies. Time and time again throughout this process, we’ve seen...
Oct 7, 2019 75
It may come to that if a key policy isn’t changed. Action Alert! As part of its effort to implement the Drug Quality and Security Act of 2013, the FDA issued a revision of a bad policy that will limit the amount of medicines compounding pharmacies can send out of state. The revision offers some...
Sep 26, 2019 57
A Senate committee has approved language on CBD that will not protect consumer access to CBD supplements. Action Alert! Two weeks ago, we reported on efforts to preserve consumer access to therapeutic levels of CBD oil in supplements. The US Senate Appropriations Committee has approved report la...